Allogeneic mesenchymal stem cell–derived exosome

· Isfahan University of Medical Sciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Allogeneic mesenchymal stem cell–derived exosome, covering 2021-01-25 to 2021-01-25. Get the full timeline:

Most recent: Clinical Trial Update: Allogenic Mesenchymal Stem Cell Derived Exosome in Patients With Acute Ischemic Stroke [Phase 1, Phase 2]